These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23595105)

  • 1. Novel functional imaging of changes in small airways of patients treated with extrafine beclomethasone/formoterol.
    Vos W; De Backer J; Poli G; De Volder A; Ghys L; Van Holsbeke C; Vinchurkar S; De Backer L; De Backer W
    Respiration; 2013; 86(5):393-401. PubMed ID: 23595105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of extrafine beclometasone/formoterol (BDP/F) on lung function, dyspnea, hyperinflation, and airway geometry in COPD patients: novel insight using functional respiratory imaging.
    De Backer J; Vos W; Vinchurkar S; Van Holsbeke C; Poli G; Claes R; Salgado R; De Backer W
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):88-99. PubMed ID: 25004168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects on small airway obstruction of long-term treatments with beclomethasone/formoterol hydrofluoroalkane (metered-dose inhaler) versus fluticasone/salmeterol (dry-powder inhaler) in asthma: a preliminary study.
    Corda L; Gardenghi GG; Modina D; Montemurro LT; Novali M; Tantucci C
    Allergy Asthma Proc; 2011; 32(6):29-34. PubMed ID: 22221427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma.
    Scichilone N; Battaglia S; Sorino C; Paglino G; Martino L; Paternò A; Santagata R; Spatafora M; Nicolini G; Bellia V
    Allergy; 2010 Jul; 65(7):897-902. PubMed ID: 20121764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment response according to small airways disease status: The effects of high-strength extrafine pMDI beclomethasone dipropionate/formoterol fumarate in fixed dose combination in moderate uncontrolled asthmatic patients.
    Carpagnano GE; Scioscia G; Lacedonia D; Stornelli SR; Irene Quarato CM; Soccio P; Resta O; Foschino Barbaro MP
    Pulm Pharmacol Ther; 2020 Feb; 60():101879. PubMed ID: 31866498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stepping-across controlled asthmatic patients to extrafine beclometasone/formoterol combination.
    Barnes N; van Noord JA; Brindicci C; Lindemann L; Varoli G; Perpiña M; Guastalla D; Casula D; Patel S; Chanez P;
    Pulm Pharmacol Ther; 2013 Oct; 26(5):555-61. PubMed ID: 23524015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extrafine beclomethasone/formoterol combination via a dry powder inhaler (NEXThaler(®)) or pMDI and beclomethasone monotherapy for maintenance of asthma control in adult patients: A randomised, double-blind trial.
    Kanniess F; Scuri M; Vezzoli S; Francisco C; Petruzzelli S
    Pulm Pharmacol Ther; 2015 Feb; 30():121-7. PubMed ID: 25088067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid effects of extrafine beclomethasone dipropionate/formoterol fixed combination inhaler on airway inflammation and bronchoconstriction in asthma: a randomised controlled trial.
    O'Connor BJ; Collarini S; Poli G; Brindicci C; Spinola M; Acerbi D; Barnes PJ; Leaker B
    BMC Pulm Med; 2011 Dec; 11():60. PubMed ID: 22188731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.
    Popov TA; Petrova D; Kralimarkova TZ; Ivanov Y; Popova T; Peneva M; Odzhakova T; Ilieva Y; Yakovliev P; Lazarova T; Georgiev O; Hodzhev V; Hodzheva E; Staevska MT; Dimitrov VD
    Pulm Pharmacol Ther; 2013 Dec; 26(6):624-9. PubMed ID: 23769863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of beclometasone dipropionate/formoterol extra-fine fixed combination on the peripheral airway inflammation in controlled asthma.
    Bulac S; Cimrin A; Ellidokuz H
    J Aerosol Med Pulm Drug Deliv; 2015 Apr; 28(2):82-7. PubMed ID: 25050594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial.
    Papi A; Corradi M; Pigeon-Francisco C; Baronio R; Siergiejko Z; Petruzzelli S; Fabbri LM; Rabe KF
    Lancet Respir Med; 2013 Mar; 1(1):23-31. PubMed ID: 24321801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-life effectiveness of extrafine beclometasone dipropionate/formoterol in adults with persistent asthma according to smoking status.
    Brusselle G; Peché R; Van den Brande P; Verhulst A; Hollanders W; Bruhwyler J
    Respir Med; 2012 Jun; 106(6):811-9. PubMed ID: 22357130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrafine HFA-beclomethasone-formoterol vs. nonextrafine combination of an inhaled corticosteroid and a long acting β2-agonist in patients with persistent asthma: A systematic review and meta-analysis.
    Liu T; Yang D; Liu C
    PLoS One; 2021; 16(9):e0257075. PubMed ID: 34478483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma.
    Papi A; Paggiaro P; Nicolini G; Vignola AM; Fabbri LM;
    Allergy; 2007 Oct; 62(10):1182-8. PubMed ID: 17845589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do inhaled corticosteroid/long-acting beta2-agonist fixed combinations provide superior clinical benefits compared with separate inhalers? A literature reappraisal.
    Barnes PJ; Nicolini G; Bizzi A; Spinola M; Singh D
    Allergy Asthma Proc; 2012; 33(2):140-4. PubMed ID: 22525390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of beclomethason/formoterol and budesonide/formoterol fixed combinations on lung function and airway inflammation in patients with mild to moderate asthma--an exploratory study.
    Kirsten AM; Watz H; Brindicci C; Piccinno A; Magnussen H
    Pulm Pharmacol Ther; 2015 Apr; 31():79-84. PubMed ID: 25194884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of extrafine formulation of BDP/FF inhaler on asthma control, small airway function and airway inflammation among Mexican asthmatic patients. A retrospective analysis.
    Díaz-García R; Flores-Ramírez G; Ramírez-Oseguera RT
    Respir Med; 2020; 165():105932. PubMed ID: 32308205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small airway inflammation and extrafine inhaled corticosteroids plus long-acting beta
    Pirina P; Foschino Barbaro MP; Paleari D; Spanevello A
    Respir Med; 2018 Oct; 143():74-81. PubMed ID: 30261996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung function and asthma control with beclomethasone and formoterol in a single inhaler.
    Huchon G; Magnussen H; Chuchalin A; Dymek L; Gonod FB; Bousquet J
    Respir Med; 2009 Jan; 103(1):41-9. PubMed ID: 18977646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled beclometasone dipropionate/formoterol fumarate extrafine fixed combination for the treatment of asthma.
    Crisafulli E; Zanini A; Pisi G; Pignatti P; Poli G; Scuri M; Chetta A
    Expert Rev Respir Med; 2016; 10(5):481-90. PubMed ID: 26938578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.